Epigenetic Reactivation of SOCS-3 and Inhibition of ERK1/2 Underlie Thymoquinone-Induced Apoptosis in a Chronic Myeloid Leukemia Xenograft Model
Medical Principles and Practice · 23.05.2026 · 1-18
DOI: 10.1159/000552709 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Principles and Practice, online erschienen am 23.05.2026. Verfasst von Futoon Abedrabbu Al-Rawashde und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Balqa Applied University, Al-Salt, Jordan, futoonrawashdeh@bau.edu.…. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
This research aimed to assess thymoquinone (TQ)’s potential to demethylate and re-express the suppressor of cytokine signaling-3 (SOCS-3) in the chronic myeloid leukemia (CML) mice model. Subject and Methods: A nude mouse model of CML was established, and the apoptotic influence of TQ was identified. TQ’s impact on the target gene expressions was examined using real-time quantitative PCR (RT-qPCR), and SOCS-3 methylation was assessed by pyrosequencing. TQ’s effects on the extracellular signal-regulated kinase 1 (ERK1) and ERK2 phosphorylation were assessed using Jess Simple Western analysis. Molecular docking of TQ’s interaction with the anti-apoptotic proteins was assessed.
Results
TQ exerted a marked hypomethylating influence on SOCS-3 and reduced ERK1/2 phosphorylation level in K562-xenograft tumors. TQ also significantly upregulated the apoptosis-related cysteine peptidase (Caspase-3), BCL-2-interacting mediator of cell death (Bim), p53-upregulated modulator of apoptosis (PUMA), and other apoptotic genes and downregulated B-cell lymphoma 2 (BCL-2), BCL2-like 2 (BCL-w), survivin, and X-linked inhibitor of apoptosis (XIAP) in K562 cells. TQ also exhibited marked inhibitory properties on BCL-2-related gene expressed in fetal liver (BFL-1), B-cell lymphoma-extra large (BCL-xL), myeloid cell leukemia-1 (MCL-1), and BCL-2 proteins. This led to growth inhibition and apoptosis of the K562-tumour xenograft.
Conclusion
These results indicate that TQ enhances CML cells’ apoptosis by hypomethylating and re-expressing SOCS-3, inhibiting ERK1/2, and modulating the apoptosis-regulator gene expression and by showing consistent interaction with most of the anti-apoptotic proteins, highlighting its potential as a scaffold for designing novel inhibitors to combat CML cells.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Balqa Applied University, Al-Salt, Jordan, futoonrawashdeh@bau.edu.jo.
- Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Balqa Applied University, Al-Salt, Jordan.
- Department of Allied Medical Sciences, Zarqa College, Al-Balqa Applied University, Zarqa, Jordan.
- School of Science and Engineering, The American University in Cairo, New Cairo, Egypt.
- Department of Biochemistry, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
- School of Biomedicine, Faculty of Health Sciences, Universiti Sultan Zainal Abidin, Kuala Nerus, Terengganu, Malaysia.
Zitieren
APA
Al-Rawashde, F. A., Alqaraleh, M., Hasan, D., Elsayed, A., Amiludin, N. A. A. M., Al-Suede, F. S. R., & Al-Jamal, H. A. N. (2026). Epigenetic Reactivation of SOCS-3 and Inhibition of ERK1/2 Underlie Thymoquinone-Induced Apoptosis in a Chronic Myeloid Leukemia Xenograft Model. Medical Principles and Practice, 1-18. https://doi.org/10.1159/000552709
Vancouver
Al-Rawashde FA, Alqaraleh M, Hasan D, Elsayed A, Amiludin NAAM, Al-Suede FSR, et al. Epigenetic Reactivation of SOCS-3 and Inhibition of ERK1/2 Underlie Thymoquinone-Induced Apoptosis in a Chronic Myeloid Leukemia Xenograft Model. Medical Principles and Practice. 2026:1-18. doi:10.1159/000552709
BibTeX
@article{AlRawashde2026,
author = {Al-Rawashde, Futoon Abedrabbu and Alqaraleh, Moath and Hasan, Diya and Elsayed, Abdullrahman and Amiludin, Nur Anis Ashiela Mohd and Al-Suede, Fouad Saleih Resq and Al-Jamal, Hamid Ali Nagi},
title = {Epigenetic Reactivation of SOCS-3 and Inhibition of ERK1/2 Underlie Thymoquinone-Induced Apoptosis in a Chronic Myeloid Leukemia Xenograft Model},
journal = {Medical Principles and Practice},
year = {2026},
pages = {1--18},
doi = {10.1159/000552709}
}
EUVIMED